Seizure Rescue Medication: Caregiver Education in a Simulation Setting

September 2, 2020 updated by: Tobias Loddenkemper, Boston Children's Hospital

1. Design an educational quality improvement program to assess the most effective educational approach on caregiver seizure RM application. The investigators hypothesize that this educational program will improve caregiver comfort, knowledge of emergent seizure care, and time to medication application.

Specifically, the aims include:

  1. Create an educational video reviewing RM administration
  2. Develop and validate a simulation training model/mannequin for rectal diazepam administration
  3. Expand training to other seizure RMs (e.g. intranasal midazolam, buccal lorazepam) and transition the most effective educational model back to the clinics/bedside to standardize caregiver teaching throughout the department/hospital

Study Overview

Detailed Description

The investigators will implement an intervention jointly with a simulation program to determine the most effective training model: verbal instructions, instructional video, or use of a mannequin. Caregivers will undergo a training curriculum, and 60 caregivers (20 assigned to each educational model) will be matched into three groups and assigned to participate in one of three educational models in the SIM Center. Pre-and post-training questionnaires will be distributed to assess provider knowledge and comfort level. Scoring of caregiver technique administering rectal diazepam to a mannequin and time to RM administration will be obtained to compare between the three educational arms of the study. Thirty additional patients (10 per group) will not receive an assessment of caregiver technique administering RM to the mannequin prior to the educational intervention to control for exposure to the mannequin. Ultimately, the most effective educational method in this simulation pilot study will be expanded to other RM types (e.g. intranasal midazolam, buccal lorazepam), standardized, and brought back to the clinics/bedside throughout the hospital.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 80 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adult caregivers of patients with epilepsy followed at BCH with the following:

    1. At least one seizure >5 minutes
    2. Prescription for rectal diazepam rescue medication
    3. Admission for seizure/neurologic problem or neurology/epilepsy clinic visit during the enrollment period
  2. Adult caregivers of patients without epilepsy

Exclusion Criteria:

  1. Adult caregivers of epilepsy patients without a rectal diazepam prescription
  2. Non-English-speaking caregivers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Verbal Instructions on use of RM
Caregivers will undergo an educational intervention with typical training with verbal instructions and use of a rectal diazepam trainer.
Caregivers will undergo training with verbal instructions
EXPERIMENTAL: Video on use of RM
Caregivers will undergo an educational intervention with training by watching an instructional video regarding rescue medication administration
Caregivers will undergo training with an educational video
EXPERIMENTAL: Mannequin on use of RM
Caregivers will undergo an educational intervention with training by use of a mannequin to practice administering the rescue medication
Caregivers will undergo training with a mannequin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Time to RM Administration
Time Frame: Baseline and 30 minutes post-intervention
As determined by time to administer RM to mannequin
Baseline and 30 minutes post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in "RM Score"
Time Frame: Baseline and 30 minutes post-intervention
"RM Score" ("Rescue Medication Score") assessing caregivers' ability to administer RM with proper technique before/after training. This score will determine if caregivers were able to independently give the medication or if they required a prompt at any step. There is no maximum score, but 1 point will be given for every required prompt such that 0 is a perfect score and higher scores reflect requiring more prompts to administer the medication.
Baseline and 30 minutes post-intervention
Change in Caregiver Level of Knowledge of Medication Name
Time Frame: Baseline and 30 minutes post-intervention
Caregiver will be asked to provide medication name on a questionnaire.
Baseline and 30 minutes post-intervention
Change in Caregiver Level of Knowledge of When to Give Medication
Time Frame: Baseline and 30 minutes post-intervention
Caregiver will be asked to provide time at which medication is to be given on a questionnaire.
Baseline and 30 minutes post-intervention
Change in Caregiver Level of Knowledge of Route of Medication Administration
Time Frame: Baseline and 30 minutes post-intervention
Caregiver will be asked to provide route of medication administration on a questionnaire.
Baseline and 30 minutes post-intervention
Change in Caregiver Level of Knowledge of Medication Side Effects
Time Frame: Baseline and 30 minutes post-intervention
Caregiver will be asked to provide medication side effects on a questionnaire.
Baseline and 30 minutes post-intervention
Change in Caregiver Level of Comfort
Time Frame: Baseline and 30 minutes post-intervention
Caregiver level of comfort with administration as determined by the pre- and post-questionnaires. Caregivers will report level of comfort before and after training based on a 4-point scale (very uncomfortable, somewhat uncomfortable, somewhat comfortable, very comfortable)
Baseline and 30 minutes post-intervention
Change in Caregiver Feeling of Ease with Administration
Time Frame: Baseline and 30 minutes post-intervention
Caregiver level of ease with administration as determined by the pre- and post-questionnaires. Caregivers will fill out the short-form State-Trait Anxiety Inventory (STAI-6) on a 4-point scale (not at all, somewhat, moderately, very much)
Baseline and 30 minutes post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2018

Primary Completion (ACTUAL)

September 17, 2019

Study Completion (ACTUAL)

September 17, 2019

Study Registration Dates

First Submitted

March 6, 2018

First Submitted That Met QC Criteria

June 7, 2018

First Posted (ACTUAL)

June 19, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 4, 2020

Last Update Submitted That Met QC Criteria

September 2, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • P00027241

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Status Epilepticus

Clinical Trials on Verbal Instructions Educational Intervention

3
Subscribe